It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

The findings are similar to an analysis STAT conducted, and raise questions about why UnitedHealth pays its doctors more.

Despite no strong evidence of clinical benefit, microdosing GLP-1s will likely continue as a strategy for some to profit off of the popular drug class.

The FDA's top regulator of medicines has resigned after being accused of using his regulatory authority to harm a former ...

Late Friday, Medicare issued its final word on physician payments for 2026. The agency is following through on its earlier ...

Caribou Biosciences said its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced ...

Yesterday, STAT’s Lizzy Lawrence and Adam Feuerstein scored another exclusive: The FDA’s top drug regulator has been placed ...

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts and emails ...

George Tidmarsh denied wrongdoing at the FDA and accused senior FDA officials — including CBER chief Vinay Prasad — of wrongdoing ...